Moneycontrol
HomeNewsBusinessReal EstateOffice transactions across prime cities witness growth recovery: Knight Frank India
Trending Topics

Office transactions across prime cities witness growth recovery: Knight Frank India

New office completion recovers by 126% in Q3 2020; Four of the top eight markets witness stable or positive rent growth

October 08, 2020 / 12:06 IST
Story continues below Advertisement

Gross office leasing across top eight cities in the country witnessed a strong recovery, registering 80 percent growth to 0.44 mn sq m in the third quarter of 2020. New office completions during the same period, reported recovery of 126 percent to 0.33 mn sq m compared to second quarter of 2020, Knight Frank India’s quarterly report titled India Real Estate Update - Q3 2020, said.

As Q2 2020 was marred by lockdown, the report cited the need to evaluate commercial market recovery compared to pre-COVID levels. Thus, besides looking at a single period, i.e. Quarter on Quarter analysis, Knight Frank India established a comparative matrix of Q3 2020 recovery against the quarterly average number of transactions in the year 2019.

Story continues below Advertisement

The total office transactions of the eight markets in Q3 2020 have improved and reached 33 percent of the 2019 quarterly average level. Chennai, National Capital Region (NCR), and Mumbai recorded higher recovery in Q3 2020 with transactions reaching the level of 57 percent, 43 percent and 42 percent  respectively of the quarterly average of the year 2019, the report said.

New completions also improved to 29 percent  of the 2019 quarterly average. In terms of new completions in Q3 2020, Ahmedabad was the only market to report higher new office completions, 125 percent  of quarterly average levels of the year 2019, the report said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show